Outlook Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:41O Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Sep 24	Buy€25,451	Lawrence Kenyon	Individual	5,000	€5.09
28 Mar 24	Buy€20,591	Yezan Haddadin	Individual	1,881.71	€10.94
07 Mar 24	Buy€24,013	Jeffrey Evanson	Individual	3,124.2	€7.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 41O?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	76,212	0.238%
Private Companies	2,537,289	7.92%
Institutions	5,036,780	15.7%
VC/PE Firms	5,808,074	18.1%
General Public	18,558,824	58%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 146%.

Top Shareholders

Top 25 shareholders own 41.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.1%	GMS Ventures & Investments	5,808,074	€9.5m	0%	no data
5.33%	Syntone Technologies Group Co. Ltd.	1,705,438	€2.8m	0%	no data
3.42%	BlackRock, Inc.	1,093,522	€1.8m	4.64%	no data
2.66%	The Vanguard Group, Inc.	852,540	€1.4m	-0.39%	no data
2.6%	GMS Tenshi Holdings Pte. Limited	831,851	€1.4m	0%	no data
1.88%	Sphera Funds Management Ltd	601,050	€987.5k	45.3%	0.16%
1.08%	Geode Capital Management, LLC	347,229	€570.5k	1.54%	no data
0.9%	UBS Asset Management AG	286,644	€470.9k	3,910%	no data
0.78%	State Street Global Advisors, Inc.	248,596	€408.4k	6.9%	no data
0.59%	Rhumbline Advisers Ltd Partnership	188,050	€309.0k	1,330%	no data
0.57%	Tang Capital Management, LLC	182,502	€299.8k	-88.3%	0.02%
0.57%	FMR LLC	181,519	€298.2k	17,800%	no data
0.47%	Woodline Partners LP	151,508	€248.9k	0%	no data
0.41%	Renaissance Technologies LLC	130,374	€214.2k	0%	no data
0.35%	Northern Trust Global Investments	111,750	€183.6k	-5.99%	no data
0.31%	GSA Capital Partners LLP	100,319	€164.8k	0%	0.01%
0.25%	Susquehanna International Group, LLP, Asset Management Arm	81,275	€133.5k	0%	no data
0.23%	Scotiabank Global Banking and Markets, Asset Management Division	73,989	€121.6k	124%	no data
0.18%	AQR Capital Management, LLC	59,174	€97.2k	0%	no data
0.14%	Morgan Stanley, Investment Banking and Brokerage Investments	45,886	€75.4k	10.8%	no data
0.12%	Goldman Sachs Group, Investment Banking and Securities Investments	38,993	€64.1k	9.61%	no data
0.12%	Jeffrey Evanson	37,298	€61.3k	0%	no data
0.11%	Charles Schwab Investment Management, Inc.	36,048	€59.2k	-30%	no data
0.093%	BNY Asset Management	29,764	€48.9k	44.8%	no data
0.082%	Jane Street Group, LLC, Asset Management Arm	26,218	€43.1k	134%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 11:01
End of Day Share Price	2025/02/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Outlook Therapeutics, Inc. is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Woo	Ascendiant Capital Markets LLC
Brian Kemp Dolliver	Brookline Capital Markets
Kumaraguru Raja	Brookline Capital Markets